Intelligence · Clinical Development
Pipeline search results
Programs matching “prednisone” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 17 pipeline programs matching "prednisone" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
5 mg prednisone
Ultragenyx UK Limited
Granulomatosis With Polyangiitis
2 trials -
COLECALCIFEROL , PREDNISONE
Fondazione Telethon ETS
Elderly patients with Diffuse Large B-Cell Lymphoma (DLBCL)
1 trial -
PREDNISONE for Idiopathic IgA nephropathy (IgAN)
Fondazione Telethon ETS
Idiopathic IgA nephropathy (IgAN)
1 trial -
Supportive care+Prednisone
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Minimal Change Disease
1 trial -
prednisone
Ultragenyx UK Limited
Duchenne Muscular Dystrophy
1 trial -
60 mg Prednisone
United Therapeutics Europe Ltd
Airway Inflammation
1 trial -
Docetaxel, Reolysin and Prednisone
ONCOLYTICS BIOTECH INC
Prostate Cancer
1 trial -
Modified-Release Prednisone
United Therapeutics Europe Ltd
Chronic Inflammation
1 trial -
Prednisone
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Langerhans Cell Histiocytosis of Bone
1 trial -
Prednisone
Nanjing Children's Hospital
Henoch-Schoenlein Purpura Nephritis
1 trial -
Prednisone + Jakavi(ruxolitinib)
Yung NA
GVHD - Graft-Versus-Host Disease
1 trial -
TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Prostatic Neoplasms, Castration-Resistant
1 trial -
Prednisone
Vertex Pharmaceuticals (Australia) Pty.
Drug Interactions
1 trial -
PREDNISONE
Pari Pharma GmbH
Idiopathic retroperitoneal fibrosis
1 trial -
PREDNISONE for kidney transplantation
Disc Medicine
kidney transplantation
1 trial -
Prednisone
Takeda
Crohn's Disease
1 trial -
Prednisone
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Undifferentiated Connective Tissue Disease
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.